PE symptoms, like hypertension, proteinuria, fetal growth restriction, and kidney injury, were observed in SIRT1-knockdown mice, and these symptoms improved upon administration of SRT2104 (Table 3), an allosteric activator that binds to the N-terminus of SIRT1 [66,68]. The gene discussed is SIRT1; the disease is hypertensive disorder.